Clinical features of endometrial polyps in postmenopausal women

DOI: https://doi.org/10.29296/25877305-2021-05-07
Download full text PDF
Issue: 
5
Year: 
2021

Professor Т. Klinyshkova(1), MD; N. Frolova(2), Candidate of Medical Sciences; E. Soveyko(3);
N. Сhernyshova(2) (1)Omsk State Medical University (2)Clinical hospital of Russian Railways-Medicine, Omsk
(3)Clinical and diagnostic center «Ultramed», Omsk

The incidence of cancer of the uterine body in recent years is in the first place in the structure of genital cancers. Endometrial polyps (PE) are an actual gynecological problem from the point of view of cancer risk, increased in the postmenopausal period. The aim of the study was to conduct a quantitative analysis of the clinical features of the course of PE in postmenopausal patients. Material and methods. A retrospective cohort study was performed on the basis of the gynecological department of the CHUZ «CB «Russian Railways-Medicine» Omsk». The research cohort consisted of 133 postmenopausal women with PE (mean age-59.23±6.34 years) who underwent hysteroscopic polypectomy. Results. The duration of postmenopause was 9.47±6.66 years. PE was dominant in late postmenopausal women (68.4%). Postmenopausal PE patients had asymptomatic course (69.2%), uterine bleeding (30.8%), recurrent PE (15.8%), concomitant tamoxifen treatment (3.8%). According to the hysteroscopy data, single PE (75.2%) with an average size of 15.7±9.4 mm prevailed. The predominance of glandular-fibrous PE (61.7%) is characteristic of glandular PE (36.8%) and adenomatous PE (1.5%). Signs of malignancy of adenomatous PE and cancer in the surrounding endometrium were found in the symptomatic (n=41) and asymptomatic course of the disease (n=92) (p>0.05). Conclusion. In postmenopausal patients with asymptomatic PE and PE associated with postmenopausal bleeding, the disease occurs against the background of precancerous and endometrial cancer (in the polyp or surrounding endometrium) in 3.76% of cases, which requires histological verification when detecting proliferative endometrial processes in postmenopausal ultrasound, regardless of the size of the polyp and the absence of clinical manifestations.

Keywords: 
endometrial polyp
postmenopause
hysteroscopic polypectomy
malignancy
endometrial cancer



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Sostojanie onkologicheskoj pomoschi naseleniju Rossii v 2019 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shahzadovoj. M.: MNIOI im. P.A. Gertsena – filial FGBU «NMITs radiologii» Minzdrava Rossii, 2020; 239 s. [Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2019 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shakhzadovoi. M.: MNIOI im. P.A. Gertsena – filial FGBU «NMITs radiologii» Minzdrava Rossii, 2020; 239 s. (in Russ.)].
  2. Klinyshkova T.V., Turchaninov D.V., Frolova N.B. Kliniko-epidemiologicheskie aspekty raka tela matki s pozitsii profilaktiki retsidivirovanija giperplazii. Akusherstvo i ginekologija. 2020; 1: 135–40 [Klinyshkova T. V., Turchaninov D. V., Frolova N. B. Clinical and epidemiological aspects of uterine body cancer from the perspective of prevention of recurrent hyperplasia. Obstetrics and Gynecology. 2020; 1: 135–40 (in Russ.)]. DOI: 10.18565/aig.2020.1.135-140
  3. Lee S.C., Kaunitz A.M., Sanchez-Ramos L. et al. The oncogenic potential of endometrial polyps: a systematic review and meta-analysis. Obstet Gynecol. 2010; 116 (5): 1197–205. DOI: 10.1097/AOG.0b013e3181f74864
  4. Namazov A., Gemer O., Ben-Arie A. et al. Endometrial Polyp Size and the Risk of Malignancy in Asymptomatic Postmenopausal Women. J Obstet Gynaecol Can. 2019; 41 (7): 912–5. DOI: 10.1016/j.jogc.2018.07.019
  5. Chernuha G.E., Asaturova A.V., Ivanov I.A. i dr. Struktura patologii endometrija v razlichnye vozrastnye periody. Akusherstvo i ginekologija. 2018; 8: 129–34 [Chernukha G.E., Asaturova A.V., Ivanov I.A. et al. Structure of endometrial pathology in various age periods. Obstetrics and Gynecology. 2018; 8: 129–34 (in Russ.)]. DOI: 10.18565/aig.2018.8.129-134
  6. Sasaki L.M.P., Andrade K.R.C., Figueiredo A.C.M.G. et al. Factors Associated With Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2018; 25 (5): 777–85. DOI: 10.1016/j.jmig.2018.02.004
  7. Mamaev A.N., Kudlaj D.A. Statisticheskie metody v meditsine. M.: Prakticheskaja meditsina, 2021; 136 s. [Mamaev A.N., Kudlay D.A. Statisticheskie metody v meditsine. M.: Prakticheskaya meditsina, 2021; 136 s. (in Russ.)].
  8. Klinyshkova T.V., Frolova N.B., Mozgovoj S.I. Klinicheskoe znachenie kompleksnoj otsenki retseptornogo statusa endometrija pri endometrial'nyh polipah. Akusherstvo i ginekologija. 2011; 3: 37–41 [Klinyshkova T.V., Frolova N.B., Mozgovoy S.I. The clinical significance of a comprehensive assessment of the endometrial receptor status in endometrial polyps. Obstetrics and Gynecology. 2011; 3: 37–41(in Russ.)].
  9. Sarkisov S.E., Mamikonjan I.O., Pavlovich S.V. i dr. Elektrohirurgicheskaja bi- i monopoljarnaja destruktsija endometrija v profilaktike retsidivov tamoksifen-assotsirovannoj patologii endometrija v postmenopauze. Akusherstvo i ginekologija. 2018; 5: 78–84 [Sarkisov S.E., Mamikonyan I.O., Pavlovich S.V. et al. Electrosurgical bi-and monopolar destruction of the endometrium in the prevention of relapses of tamoxifen-associated endometrial pathology in postmenopause. Obstetrics and Gynecology. 2018; 5: 78–84 (in Russ.)]. DOI: 10.18565/aig.2018.5.78-84
  10. Wortman M. «See-and-Treat» Hysteroscopy in the Management of Endometrial Polyps. Surg Technol Int. 2016; 28: 177–84.
  11. Elyashiv O., Sagiv R., Kerner R. et al. Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy? J Minim Invasive Gynecol. 2017; 24 (7): 1200–3. DOI: 10.1016/j.jmig.2017.08.002
  12. Adomaitiene L., Nadisauskiene R., Nickkho-Amiry M. et al. Tumor Suppression in Asymptomatic Postmenopausal Endometrial Polyps. Anticancer Res. 2020; 40 (2): 789–94. DOI: 10.21873/anticanres.14010
  13. Ghoubara A., Sundar S., Ewies A.A.A. Predictors of Malignancy in Endometrial Polyps: Study of 421 Women With Postmenopausal Bleeding. Climacteric. 2018; 21 (1): 82–7. DOI: 10.1080/13697137.2017.1410783
  14. Jacobs I., Tibosch R., Geomini P. et al. Atypical endometrial polyps and the incidence of endometrial cancer: a retrospective cohort study. BJOG. 2020; 127 (8): 994–9. DOI: 10.1111/1471-0528.16194
  15. Cavkaytar S., Kokanali M.K., Ceran U. et al. Roles of sonography and hysteroscopy in the detection of premalignant and malignant polyps in women presenting with postmenopausal bleeding and thickened endometrium. Asian Pac J Cancer Prev. 2014; 15 (13): 5355–8. DOI: 10.7314/apjcp.2014.15.13.5355